The Safety and Efficacy of a Novel HSP90 Inhibitor (CUDC-305) in the Treatment of Moderate to Severe Psoriasis.
Clinical trial NCT03675542 · UNKNOWN
Trial details
- NCT number
- NCT03675542
- Sponsor
- Aarhus University Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-01
- Primary completion
- 2019-11-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.